Home
Explore
Substances
Ailments
Problem Substances
Therapeutic Actions
Problematic Actions
Pharmacological Actions
Adverse Pharmacological Actions
Keywords
Health Guides
Recent Comments
Authors
GMTV
Tools
SS - Query Diseases
SS - Query Pharmacological Actions
SS - Query Substances
Articles
Most Popular
Most Recent
Eatmology
Store
Membership Options
Books
Downloadable Documents
Events
Event Videos
GMI Tokens
Donate
My Account
My Comments
My Cart
My Newsletters
FAQ
Contact
Search this site:
Search
Download Now
Your Token Count
0
Sign in to Purchase/Download Documents
Sign in
/
Register
User login
Username or e-mail:
*
Password:
*
Log in
Create new account
Request new password
Social Networking
Support Free Media
Become A Sponsor
View Our Sponsors
Advertise/Collaborate
Become a Member
Become an Affiliate
Link To Us
About Us
Naringenin
0
Tweet
User Options
Hover over an icon for more information
Additional Topics Details for this Page
Article Count
- 12
Cumulative Knowledge
- 17
Advanced Database Options
Limit Articles Displayed by the Following Study Types
Animal Study
In Vitro Study
Submit
Available Sorting Options
Limited to Members Only
By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by
clicking here
. If you do not currently have a user account, and would like to create one/become a member,
click here
to begin the singup process.
Currently Available Sorting Options
Article Published Date
- Sort all displayed articles by their published date
Quick Summary Fieldsets
- Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge
- Default sorting method. Allows you to sort descendingly
What is Cumulative Knowledge?
Cumulative Knowledge
is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.
Click here for a more thorough explanation.
Quick Summary: Current access displays 2 out of 22 associated Diseases
Name
Cumulative Knowledge
Article Count
Focus Articles
Alcoholic Liver Disease
2
1
Log in
|
Sign up
Cadmium Poisoning
2
1
Log in
|
Sign up
Quick Summary: Current access displays 2 out of 11 associated Pharmacological Actions
Name
Cumulative Knowledge
Article Count
Focus Articles
Antioxidants
10
6
Log in
|
Sign up
Apoptotic
2
2
Log in
|
Sign up
Currently Viewing Free Sample of Member Only Features
Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "
Cumulative Knowledge
" (
learn more
).
The
Focus Article Feature
is not enabled.
Upgrading to the
Member
role gives you access to unlimited rows of Cumulative Knowledge data.
To Participate
Click here
to login
Click here
to create an account
View the Evidence: Substances
Curcumin and naringenin exhibit neuroprotective properties in an animal model of Parkinson's disease.
Click here to read the entire abstract
Pubmed Data
: Free Radic Res. 2005 Oct;39(10):1119-25. PMID:
16298737
Article Published Date
: Oct 01, 2005
Study Type
: Animal Study
Additional Links
Substances
:
Curcumin : CK(2910) : AC(1482)
,
Naringenin : CK(17) : AC(12)
Diseases
:
Parkinson Disease : CK(543) : AC(79)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
,
Neuroprotective Agents : CK(962) : AC(480)
Naringenin has a beneficial effect on lipid peroxidation and antioxidant status in rats with ethanol-induced liver toxicity.
Click here to read the entire abstract
Pubmed Data
: J Pharm Pharmacol. 2009 Oct;61(10):1383-90. PMID:
19814872
Article Published Date
: Oct 01, 2009
Study Type
: Animal Study
Additional Links
Substances
:
Naringenin : CK(17) : AC(12)
Diseases
:
Alcoholic Liver Disease : CK(146) : AC(50)
,
Chemically-Induced Liver Damage : CK(475) : AC(175)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
,
Hepatoprotective : CK(557) : AC(272)
Naringenin protects against cadmium-induced oxidative kidney dysfunction in rats.
Click here to read the entire abstract
Pubmed Data
: Toxicology. 2009 Feb 4;256(1-2):128-34. Epub 2008 Nov 21. PMID:
19063931
Article Published Date
: Feb 04, 2009
Study Type
: Animal Study
Additional Links
Substances
:
Naringenin : CK(17) : AC(12)
Diseases
:
Cadmium Poisoning : CK(64) : AC(30)
,
Kidney Damage : CK(120) : AC(42)
,
Oxidative Stress : CK(1945) : AC(710)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
Naringenin significantly reduces lung metastases in mice with pulmonary fibrosis and increases their survival by improving immune function.
Click here to read the entire abstract
Pubmed Data
: Cancer Res. 2009 Apr 1;69(7):3205-12. Epub 2009 Mar 24. PMID:
19318568
Article Published Date
: Apr 01, 2009
Study Type
: Animal Study
Additional Links
Substances
:
Naringenin : CK(17) : AC(12)
Diseases
:
Lung Cancer : CK(496) : AC(198)
,
Pulmonary Fibrosis : CK(135) : AC(46)
The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow.
Click here to read the entire abstract
Pubmed Data
: Mutat Res. 2002 Aug 26;519(1-2):37-48. PMID:
12160890
Article Published Date
: Aug 26, 2002
Study Type
: Animal Study
Additional Links
Substances
:
Flavonoids : CK(909) : AC(289)
,
Grapefruit : CK(109) : AC(30)
,
Naringenin : CK(17) : AC(12)
Diseases
:
DNA damage : CK(711) : AC(293)
,
Radiation Induced Illness : CK(1018) : AC(249)
,
Radiation Induced Illness: Bone Marrow : CK(22) : AC(13)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
,
Radioprotective : CK(456) : AC(183)
Bitter Orange (Citrus aurantium) may have anti-atherogenic effects.
Click here to read the entire abstract
Pubmed Data
: Phytother Res. 2008 Aug 8. PMID:
18690615
Article Published Date
: Aug 08, 2008
Study Type
: In Vitro Study
Additional Links
Substances
:
Bitter Orange : CK(1) : AC(1)
,
Hesperidin : CK(160) : AC(38)
,
Naringenin : CK(17) : AC(12)
Diseases
:
Adiponectin: Low Levels : CK(88) : AC(25)
,
Atherosclerosis : CK(523) : AC(77)
Flavanoid rich honey may act as chemosensitizers in multidrug resistant cancers.
Click here to read the entire abstract
Pubmed Data
: Med Hypotheses. 2011 Jan 17. Epub 2011 Jan 17. PMID:
21247706
Article Published Date
: Jan 17, 2011
Study Type
: In Vitro Study
Additional Links
Substances
:
Biochanin A : CK(9) : AC(8)
,
Chrysin : CK(15) : AC(12)
,
Flavonoids : CK(909) : AC(289)
,
Genistein : CK(450) : AC(174)
,
Honey : CK(251) : AC(50)
,
Kaempferol : CK(27) : AC(22)
,
Naringenin : CK(17) : AC(12)
,
Quercetin : CK(318) : AC(136)
Diseases
:
Cancers: Multi-Drug Resistant : CK(92) : AC(73)
Pharmacological Actions
:
Chemosensitizer : CK(197) : AC(159)
Flavonoids increase the resistance of LDL to oxidation and glycation.
Click here to read the entire abstract
Pubmed Data
: J Agric Food Chem. 2009 Jun 10;57(11):5058-64. PMID:
19489629
Article Published Date
: Jun 10, 2009
Study Type
: In Vitro Study
Additional Links
Substances
:
Flavonoids : CK(909) : AC(289)
,
Kaempferol : CK(27) : AC(22)
,
Luteolin : CK(62) : AC(51)
,
Naringenin : CK(17) : AC(12)
Diseases
:
Advanced Glycation End products (AGE) : CK(2114) : AC(40)
,
Cholesterol: Oxidation : CK(457) : AC(98)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
Naringenin inhibits lipopolysaccharide induced inflammation and may contribute to treating inflammatory diseases like periodontitis.
Click here to read the entire abstract
Pubmed Data
: J Periodontal Res. 2008 Aug;43(4):400-7. PMID:
18503517
Article Published Date
: Aug 01, 2008
Study Type
: In Vitro Study
Additional Links
Substances
:
Naringenin : CK(17) : AC(12)
Diseases
:
Periodontitis : CK(61) : AC(14)
Naringenin may have therapeutic value in contact hypersensitivity supression.
Click here to read the entire abstract
Pubmed Data
: Biochem Biophys Res Commun. 2010 Jun 25;397(2):163-9. Epub 2010 May 22. PMID:
20471963
Article Published Date
: Jun 25, 2010
Study Type
: In Vitro Study
Additional Links
Substances
:
Naringenin : CK(17) : AC(12)
Diseases
:
Hypersensitivity : CK(64) : AC(15)
,
Hypersensitivity: Immediate : CK(93) : AC(9)
Pharmacological Actions
:
Antioxidants : CK(3653) : AC(1318)
,
Apoptotic : CK(1489) : AC(1114)
,
Immunosuppressive Agents : CK(26) : AC(19)
Naringenin, and related compounds, have anti-androgenic properties.
Click here to read the entire abstract
Pubmed Data
: Planta Med. 2003 Sep;69(9):856-8. PMID:
14598215
Article Published Date
: Sep 01, 2003
Study Type
: In Vitro Study
Additional Links
Substances
:
Citrus naringin : CK(12) : AC(8)
,
Naringenin : CK(17) : AC(12)
Diseases
:
Androgen-Induced Diseases : CK(49) : AC(20)
Pharmacological Actions
:
Anti-Androgen : CK(58) : AC(15)
The dietary flavonoids luteolin, apigenin, chrysin and naringenin (found in fruits and vegetables) are potent natural proteasome inhibotrs and tumor cell death inducers.
Click here to read the entire abstract
Pubmed Data
: Front Biosci. 2007;12:1935-45. Epub 2007 Jan 1. PMID:
17127432
Article Published Date
: Jan 01, 2007
Study Type
: In Vitro Study
Additional Links
Substances
:
Apigenin : CK(76) : AC(51)
,
Chrysin : CK(15) : AC(12)
,
Flavonoids : CK(909) : AC(289)
,
Fruit: All : CK(1836) : AC(472)
,
Luteolin : CK(62) : AC(51)
,
Naringenin : CK(17) : AC(12)
,
Vegetables: All : CK(551) : AC(69)
Diseases
:
Cancers: All : CK(9062) : AC(2869)
,
Tumors : CK(197) : AC(110)
Pharmacological Actions
:
Anticarcinogenic Agents : CK(521) : AC(275)
,
Apoptotic : CK(1489) : AC(1114)
,
Chemopreventive : CK(1528) : AC(382)
,
Proteasome Inhibitors : CK(41) : AC(27)
Print Options
Some features are currently member only features. If you are already a member, please
login
. Otherwise,
click here
to become a member.
Printer-friendly version
Send to friend
PDF version
Privacy Policy
Return Policy
About Us
Contact Us
Sitemap